REGISTERED NUMBER: 04110775 (England and Wales)

Medics Worldwide Limited

Unaudited Financial Statements

for the Year Ended 31 March 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Professor MH Wilson

Mrs JDE Rodger

Mrs RDJ Fornasier

Mrs MSJ Watson

SECRETARY:

H Wilson

REGISTERED OFFICE:

Crossways Church Road

Halstead

Sevenoaks

Kent

TN14 7HF

REGISTERED NUMBER:

04110775 (England and Wales)

ACCOUNTANTS:

McMillan & Co LLP

Chartered Accountants

28 Eaton Avenue

Matrix Office Park

Buckshaw Village

Chorley

Lancashire

PR7 7NA

FIXED ASSETS

Tangible assets

4

2,337,021

2,360,238

CURRENT ASSETS

Debtors

5

3,301

4,931

Cash at bank

29,963

47,367

33,264

52,298

CREDITORS

Amounts falling due within one year

6

146,218

82,662

NET CURRENT LIABILITIES

(112,954

)

(30,364

)

TOTAL ASSETS LESS CURRENT LIABILITIES

2,224,067

2,329,874

CREDITORS

Amounts falling due after more than one year

7

750,000

780,500

NET ASSETS

1,474,067

1,549,374

CAPITAL AND RESERVES

Called up share capital

8

64

64

Capital redemption reserve

32

32

Retained earnings

1,473,971

1,549,278

SHAREHOLDERS' FUNDS

1,474,067

1,549,374

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 December 2025 and were signed on its behalf by:

Mrs MSJ Watson - Director

1.	STATUTORY INFORMATION

Medics Worldwide Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

The amounts in the financial statements have been rounded to the nearest £1.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on reducing balance

Motor vehicles

-

25% on reducing balance

Freehold land is not depreciated. No depreciation is provided on the company's freehold and long leasehold buildings as the directors consider that the lives of these assets are so long and residual values, based on prices prevailing at the time of acquisition, are sufficiently high that any depreciation would be immaterial. Provision is made in the profit and loss account in the event of any permanent diminution in the value of the properties. Investment properties are shown at their most recent valuation. In accordance with FRS102, the company's properties are held for long term investment and are included in the balance sheet at their open market values. The surpluses or deficits on the annual revaluation of such properties are transferred to the profit and loss account. Depreciation is not provided in respect of freehold investment properties.

Financial instruments

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument. Basic financial assets, which include debtors, prepayments and bank balances, are initially measured at transaction price and are subsequently carried at cost unless the arrangement indicates otherwise and then the asset is measured at the present value of the future receipts discounted at a market rate of interest. Basic financial liabilities, which include creditors, accruals, bank loans and group borrowings, are initially recognised at transaction price and are subsequently carried at cost unless the arrangement indicates otherwise and then the liability is measured at the present value of the future obligations discounted at a market rate of interest.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

and

Motor

property

fittings

vehicles

Totals

£

£

£

£

COST

At 1 April 2024

and 31 March 2025

2,267,370

23,738

165,579

2,456,687

DEPRECIATION

At 1 April 2024

-

18,806

77,643

96,449

Charge for year

-

1,233

21,984

23,217

At 31 March 2025

-

20,039

99,627

119,666

NET BOOK VALUE

At 31 March 2025

2,267,370

3,699

65,952

2,337,021

At 31 March 2024

2,267,370

4,932

87,936

2,360,238

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Prepayments

3,301

4,931

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

216

204

Taxation and social security

661

1,397

Other creditors

145,341

81,061

146,218

82,662

The amounts outstanding on the directors' current accounts of £138,524 (2024: £44,356) are included in other creditors They are unsecured, interest free and have no fixed repayment terms.

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Other creditors

750,000

780,500

The amounts outstanding on the directors' current accounts of £750,000 (2024: £780,500) are included in other creditors They are unsecured, interest free and have no fixed repayment terms.

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

16

Ordinary A

£1

16

16

16

Ordinary B

£1

16

16

16

Ordinary C

£1

16

16

16

Ordinary D

£1

16

16

64

64

9.	RELATED PARTY DISCLOSURES

In the opinion of the directors the company is controlled by the directors by virtue of their shareholdings.